New radiation method aims to reduce side effects in cervical cancer treatment

NCT ID NCT07585929

Recruiting now Symptom relief Sponsor: All India Institute of Medical Sciences Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a newer, more precise type of radiation called SBRT for women with stage IIIC cervical cancer. The goal is to see if it can safely deliver high doses to cancer in the pelvic lymph nodes while causing fewer side effects than standard radiation. About 150 women will take part, and the main focus is on tracking any serious short-term side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL CANCER STAGE IIIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cervical cancer cervical carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CERVIX CANCER STAGE IIIC

Contacts and locations

Locations

All India Institute of Medical Sciences
RECRUITING

Delhi, National Capital Territory of Delhi, 110049, India
Karun Kamboj
RECRUITING

Delhi, National Capital Territory of Delhi, 110049, India
National Cancer Institute, All India Institute of Medical Sciences, New Delhi, India
RECRUITING

New Delhi, New Delhi, 110029, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.